Adagio Medical Holdings IncADGM
ASignal's systematic analysis rates ADGM as Bearish.
Reflects the latest available analysis · analyzed Aug 20, 2026
The case on ADGM
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- MACD above signal line indicating short-term bullish momentum
- Price above 20-day SMA and near Bollinger upper band suggesting potential breakout
- Current ratio of 1.41x indicates near-term liquidity adequacy
- Negative price momentum trend (-0.073)
- Extremely weak fundamentals: negative margins across all levels
- Negative return on equity (-657.76%) and negative price-to-book (-33.37x)
- Negative free cash flow (-$7.90M) and operating cash flow (-$16.53M)
- Lack of Reddit sentiment data and minimal news coverage
- Forward P/E of -0.55x indicates unprofitable earnings outlook
See the full verdict on ADGM
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ADGM
Most investors never get a second opinion, let alone several. ASignal runs ADGM past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.